Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study

doi:10.3748/wjg.v26.i6.657

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10196)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

446

WORD

224

HTML

4671

Figures (1-4)

442

Tables (1-4)

336

Sum=6119

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

878

Download

844

Sum=1722

Publishing Process of This Article

Item

Count

Browse

840

Download

1515

Sum=2355

Feb 14, 2020 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 14, 2020; 26(6): 657-669
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.657

Full Size Figure Download Figure

Figure 4 Survival curves between candidates and non-candidates according to sequential use of the Hepatoma Arterial-embolization Prognostic system version 3 and alpha-fetoprotein, BCLC stage, Child-Pugh and Response system. re-TACE: Repeated transarterial chemoembolization.

Citation: Wang ZX, Wang EX, Bai W, Xia DD, Mu W, Li J, Yang QY, Huang M, Xu GH, Sun JH, Li HL, Zhao H, Wu JB, Yang SF, Li JP, Li ZX, Zhang CQ, Zhu XL, Zheng YB, Wang QH, Li J, Yuan J, Li XM, Niu J, Yin ZX, Xia JL, Fan DM, Han GH, on behalf of China HCC-TACE Study Group. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study. World J Gastroenterol 2020; 26(6): 657-669
URL: https://www.wjgnet.com/1007-9327/full/v26/i6/657.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i6.657